Maven Biotechnologies Gets $1.9M Grant from NIAID

Maven will use the funding to further build out its technology for label-free protein microarrays and cell-based assays and commercial products.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.